Year archive

Lepu Biopharma Co., Ltd. — 2024 filings

All 55 regulatory filings released by Lepu Biopharma Co., Ltd. (2157) in 2024, sourced directly from the official regulator.

55 Filings

2024 Period

2024 filings (55)

Filing	Released	Lang
CONTINUING CONNECTED TRANSACTION Regulatory Filings	2024-12-17	English
NOTICE OF 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-12-17	English
PROXY FORM FOR USE AT THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-12-17	English
(1) CONTINUING CONNECTED TRANSACTION IN RELATION TO CDMO SERVICES FRAMEWORK AGREEMENT (2) PROPOSED CHANGE OF THE AUDITOR AND (3) NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-12-17	English
CLOSURE OF REGISTER OF MEMBERS FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETINGS TO BE HELD ON JANUARY 7, 2025 Regulatory Filings	2024-12-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-05	English
CONTINUING CONNECTED TRANSACTION CDMO SERVICES FRAMEWORK AGREEMENT Regulatory Filings	2024-11-26	English
ANNOUNCEMENT OF PROPOSED CHANGE OF AUDITOR Regulatory Filings	2024-11-26	English
CONTINUING CONNECTED TRANSACTION NEW PROCUREMENT FRAMEWORK AGREEMENT Regulatory Filings	2024-11-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-07	English
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF THE NEW DRUG APPLICATION AND PRIORITY REVIEW GRANTED BY NMPA TO MRG003 FOR THE TREATMENT OF R/M NPC Regulatory Filings	2024-09-27	English
2024 Interim Report Interim / Quarterly Report	2024-09-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Share Issue/Capital Change	2024-09-04	English
ARTICLES OF ASSOCIATION Governance Information	2024-09-02	English
AMENDMENTS TO THE ARTICLES OF ASSOCIATION Governance Information	2024-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report	2024-08-21	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-06	English
VOLUNTARY ANNOUNCEMENT BREAKTHROUGH THERAPY DESIGNATION GRANTED BY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC Regulatory Filings	2024-08-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Share Issue/Capital Change	2024-07-05	English
POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING HELD ON JUNE 19, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Share Issue/Capital Change	2024-06-06	English
Proxy Form for the Annual General Meeting to be held on June 19 2024 Proxy Solicitation & Information Statement	2024-05-28	English
(1) 2023 REPORT OF THE BOARD OF DIRECTORS (2) 2023 REPORT OF THE BOARD OF SUPERVISORS (3) 2023 ANNUAL REPORT (4) 2023 FINANCIAL ACCOUNTS REPORT (5) 2024 FINANCIAL BUDGET (6) 2023 ANNUAL PROFIT DISTRIB AGM Information	2024-05-28	English
NOTICE OF THE 2023 ANNUAL GENERAL MEETING AGM Information	2024-05-28	English
Next Day Disclosure Return Share Issue/Capital Change	2024-05-24	English
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE Capital/Financing Update	2024-05-24	English
VOLUNTARY ANNOUNCEMENT THREE CLINICAL TRIAL RESULTS PRESENTED AT 2024 ASCO ANNUAL MEETING Regulatory Filings	2024-05-24	English
Placing of New H Shares under General Mandate Capital/Financing Update	2024-05-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
2023 Annual Report Annual Report	2024-04-25	English
VOLUNTARY ANNOUNCEMENT UPDATE ON THE LICENSE AGREEMENT WITH ASTRAZENECA FOR CMG901 Capital/Financing Update	2024-04-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Annual Report	2024-03-27	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-03-15	English
VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER Regulatory Filings	2024-03-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Share Issue/Capital Change	2024-03-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Share Issue/Capital Change	2024-02-05	English
ARTICLES OF ASSOCIATION Governance Information	2024-01-31	English
List of Directors and their Roles and Functions Board/Management Information	2024-01-31	English
(1) POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 31, 2024; (2) RE-ELECTION OF DIRECTORS AND SUPERVISORS; (3) CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR&#x3 Declaration of Voting Results & Voting Rights Announcements	2024-01-31	English
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 31, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-01-31	English
NOTICE OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING Regulatory Filings	2024-01-16	English
PROXY FORM FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-01-16	English
(1) RESOLUTIONS RELATING TO THE PROPOSED RE-ELECTION OF THE BOARD OF DIRECTORS; (2) PROPOSED RE-ELECTION OF SUPERVISORS; (3) PROPOSED AMENDMENTS OF THE ARTICLES OF ASSOCIATION; AND (4) Proxy Solicitation & Information Statement	2024-01-16	English
(1) PROPOSED RE-ELECTION OF THE BOARD OF DIRECTORS; (2) RETIREMENT OF CO-CHIEF EXECUTIVE OFFICER AND DIRECTORS; (3) PROPOSED RE-ELECTION OF SUPERVISORS; AND (4) PROPOSED AMENDMENTS OF T Board/Management Information	2024-01-16	English
CONTINUING CONNECTED TRANSACTION Report Publication Announcement	2024-01-16	English
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING Regulatory Filings	2024-01-16	English
PROXY FORM FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-01-16	English
(1) CONTINUING CONNECTED TRANSACTION IN RELATION TO CDMO SERVICES FRAMEWORK AGREEMENT AND THE SUPPLEMENTAL CDMO SERVICES FRAMEWORK AGREEMENT AND (2) NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEET Proxy Solicitation & Information Statement	2024-01-16	English
Notification Letter with Request Form to Non-Registered Shareholders Regulatory Filings	2024-01-16	English
Notification Letter with Request Form to Registered Shareholders Regulatory Filings	2024-01-16	English
CLOSURE OF REGISTER OF MEMBERS FOR THE 2024 FIRST AND SECOND EXTRAORDINARY GENERAL MEETINGS TO BE HELD ON JANUARY 31, 2024 Regulatory Filings	2024-01-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-04	English